Information about Professor Gill's planned GDNF trial (from the Cure Parkinsons Trust website):

"Starting in 2011, with CPT support, Professor Gill plans to conduct a two year double blind, randomized, placebo-controlled phase 2 study of intermittent intraputamenal GDNF infusions for the treatment of Parkinson's in 36 patients. CPT's Research Committee has asked that brain imaging be included in the study to provide further evidence of the efficacy of GDNF in the brain"